Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Avidan U Neumann

Showing results (1-10 of 83) with videos related to

Pageof 9
Sort By:
Hepatology (Baltimore, Md.)|July 19, 2005
Hepatitis B viral kinetics: a dynamic puzzle still to be resolvedAvidan U Neumann
Journal of Computational Biology : a Journal of Computational Molecular Cell Biology|December 7, 2010
Partial immunity and vaccination for influenzaXinan Zhang, Yingdong Zhao, Avidan U Neumann
The Journal of Allergy and Clinical Immunology|January 9, 2020
The skin microbiome as a clinical biomarker in atopic eczema: Promises, navigation, and pitfallsMatthias Reiger, Claudia Traidl-Hoffmann, Avidan U Neumann
Statistics in Medicine|February 22, 2011
Design evaluation and optimization for models of hepatitis C viral dynamicsJeremie Guedj, Caroline Bazzoli, Avidan U Neumann, et al.
Journal of Theoretical Biology|April 25, 2009
Mathematical modeling of viral kinetics under immune control during primary HIV-1 infectionDavid Burg, Libin Rong, Avidan U Neumann, et al.
Journal of Hepatology|August 12, 2006
The extrahepatic contribution to HCV plasma viremiaHarel Dahari, Xavier Forns, Avidan U Neumann, et al.
Statistical Methods in Medical Research|March 5, 2010
Combining longitudinal discriminant analysis and partial area under the ROC curve to predict non-response to treatment for hepatitis C virusEsther Lukasiewicz, Malka Gorfine, Avidan U Neumann, et al.
Plos One|December 31, 2009
In vivo dynamical interactions between CD4 Tregs, CD8 Tregs and CD4+ CD25- cells in miceArnon Arazi, Amir Sharabi, Heidy Zinger, et al.
Journal of Hepatology|March 15, 2005
Second hepatitis C replication compartment indicated by viral dynamics during liver transplantationHarel Dahari, Anna Feliu, Montserrat Garcia-Retortillo, et al.
Lancet (London, England)|July 25, 2021
Tocilizumab in COVID-19 therapy: who benefits, and how?Avidan U Neumann, Mehmet Goekkaya, Karim Dorgham, et al.
Pageof 9

Showing results (1-10 of 83) with videos related to

Sort By:
Pageof 9
Hepatology (Baltimore, Md.)|July 19, 2005
Hepatitis B viral kinetics: a dynamic puzzle still to be resolvedAvidan U Neumann
Journal of Computational Biology : a Journal of Computational Molecular Cell Biology|December 7, 2010
Partial immunity and vaccination for influenzaXinan Zhang, Yingdong Zhao, Avidan U Neumann
The Journal of Allergy and Clinical Immunology|January 9, 2020
The skin microbiome as a clinical biomarker in atopic eczema: Promises, navigation, and pitfallsMatthias Reiger, Claudia Traidl-Hoffmann, Avidan U Neumann
Statistics in Medicine|February 22, 2011
Design evaluation and optimization for models of hepatitis C viral dynamicsJeremie Guedj, Caroline Bazzoli, Avidan U Neumann, et al.
Journal of Theoretical Biology|April 25, 2009
Mathematical modeling of viral kinetics under immune control during primary HIV-1 infectionDavid Burg, Libin Rong, Avidan U Neumann, et al.
Journal of Hepatology|August 12, 2006
The extrahepatic contribution to HCV plasma viremiaHarel Dahari, Xavier Forns, Avidan U Neumann, et al.
Statistical Methods in Medical Research|March 5, 2010
Combining longitudinal discriminant analysis and partial area under the ROC curve to predict non-response to treatment for hepatitis C virusEsther Lukasiewicz, Malka Gorfine, Avidan U Neumann, et al.
Plos One|December 31, 2009
In vivo dynamical interactions between CD4 Tregs, CD8 Tregs and CD4+ CD25- cells in miceArnon Arazi, Amir Sharabi, Heidy Zinger, et al.
Journal of Hepatology|March 15, 2005
Second hepatitis C replication compartment indicated by viral dynamics during liver transplantationHarel Dahari, Anna Feliu, Montserrat Garcia-Retortillo, et al.
Lancet (London, England)|July 25, 2021
Tocilizumab in COVID-19 therapy: who benefits, and how?Avidan U Neumann, Mehmet Goekkaya, Karim Dorgham, et al.
Pageof 9